HCA Healthcare, Inc. $HCA Shares Sold by Sterling Capital Management LLC

Sterling Capital Management LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 51,705 shares of the company’s stock after selling 4,925 shares during the quarter. Sterling Capital Management LLC’s holdings in HCA Healthcare were worth $19,808,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. ORG Partners LLC raised its stake in shares of HCA Healthcare by 27.9% during the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after buying an additional 31 shares during the last quarter. Avantax Advisory Services Inc. lifted its holdings in HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock valued at $2,791,000 after acquiring an additional 32 shares during the period. Glenview Trust co grew its stake in shares of HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares during the period. Horizon Investments LLC lifted its stake in shares of HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.5%

HCA stock opened at $471.00 on Friday. The firm has a 50-day moving average of $426.28 and a two-hundred day moving average of $390.24. The company has a market cap of $107.48 billion, a price-to-earnings ratio of 18.21, a PEG ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $478.19.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. 1.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a research note on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Robert W. Baird upped their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research report on Thursday, August 14th. Finally, Bank of America boosted their price objective on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.